Impact of different antiplatelet therapy cessation modes on outcomes in patients treated with ticagrelor with or without aspirin after PCI: the twilight-antiplatelet cessation study
Event:
ESC Congress 2022
Topic:
Pharmacotherapy
Session:
Coronary artery disease - Pharmacotherapy 3